Skip to main content

Search
News

Seattle biotech's rare approach takes cancer fight to next level

|

Seattle biotech's rare approach takes cancer fight to next level

May 28, 2014

http://www.king5.com/health/Seattle-Juno-Therapeutics-cancer-fight--260931231.html

 

Source - KING 5 TV


Medical research institutions may all target the same maladies, but they regularly compete with each other over talent and funding. So how unusual is it for three of the country's top cancer research facilities to combine their efforts to form a biotech startup company? "It is relatively rare to bring three institutions of that caliber together to collaborate rather than to compete," said Hans Bishop, CEO and co-founder of Juno Therapeutics. It's now his job to help build a business model for Juno, and commercialize the lab work that Fred Hutchinson Cancer Research Center, Seattle Children's Research Institute and New York's Memorial Sloan Kettering are pursuing in immunotherapy.

Press Contacts for Media Interviews

Email for Media Interviews
press@seattlechildrens.org
Phone for Media Interviews
206-987-4500
Monday through Friday
8:30 a.m. to 5:30 p.m. Pacific time (non-holidays)
Urgent After Hours for Media Interviews
206-987-2000
Call switchboard to page Media Relations staff on call

Latest News

The Fault in “The Fault in Our Stars”
7.24.14 — On the Pulse Blog

I loved “The Fault in Our Stars.” Both the book and the movie. I read the book a few years ago during a flight. I cried so hard ... cont.

Doctor uses scorpion venom to locate cancer cells
7.23.14 — FOX News

Dr. James Olson is a pediatric oncologist at Seattle Children’s, and the scientist who developed a compound using a protein ... cont.

Boy healing quickly after heart transplant
7.22.14 — The Columbian

In less than two weeks, Jack Conover went from being a 7-year-old in need of a heart transplant to a vibrant boy walking out of ... cont.